Control_vs_Immune_Tolerant

Control vs Immune Tolerant

p-value ≤ 0.05 3 significant 2025-09-26 00:00:00 Study: MTBLS279
11 Total Features
3 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS279_0003_00000001
Linked study
MTBLS279 — Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
Comparison
Control vs Immune Tolerant
Group A
Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.
Group B
Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase of HBV infection.
Total features tested
11
Significant features
3
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
VXUOFDJKYGDUJI-OAQYLSRUSA-N 1-myristoyl-glycero-3-phosphocholine up 2.312 8.65e-08
IGZPHNNYPPAPLA-OAQYLSRUSA-N PC(0:0/14:0) up 2.094 8.41e-06
RJZVWDTYEWCUAR-JOCHJYFZSA-N 1-Pentadecanoyl-glycero-3-phosphocholine up 1.617 9.22e-05